Science Explorer Back to mapMap

Thyroid Cancer Diagnosis and Treatment

Thyroid Cancer Diagnosis and Treatment is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 43k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management, diagnosis, and molecular genetics of thyroid cancer, including differentiated and medullary thyroid carcinoma. It covers topics such as the management guidelines for thyroid nodules, the role of BRAF mutation in papillary thyroid carcinoma, ultrasound imaging for thyroid nodules, and the use of radioactive iodine therapy. The cluster also discusses the molecular pathogenesis and genetic alterations associated with thyroid cancer.

  • Thyroid Nodules
  • Differentiated Thyroid Cancer
  • Management Guidelines
  • Thyroid Carcinoma
  • BRAF Mutation
  • Ultrasound
  • Radioactive Iodine Therapy
  • Molecular Genetics
  • Medullary Thyroid Cancer
  • Fine-Needle Aspiration
Research works
43k
fractional, since 1950
In the world top 10%
4.3k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
China
35% of the 10 largest, 2022-now
Thyroid Cancer Diagnosis and Treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Thyroid Cancer Diagnosis and Treatment research?

By volume, China and the United States publish the most (2.3k and 1.6k works in 2022-now).

By volume, 2022-now

  1. 1 China 2.3k works
  2. 2 United States 1.6k works
  3. 3 India 585 works
  4. 4 Italy 439 works
  5. 5 Türkiye 351 works
  6. 6 South Korea 349 works
  7. 7 Japan 297 works
  8. 8 Germany 216 works
  9. 9 United Kingdom 207 works
  10. 10 France 190 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 35.4%United States: 24.6%India: 8.9%Italy: 6.7%6 others listed: 24.4%35%largest
China2,338 · 35.4%United States1,623 · 24.6%India585 · 8.9%Italy439 · 6.7%6 others listed1,611 · 24.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Thyroid Cancer Diagnosis and Treatment research?

By volume in 2022-now, Shanghai Jiao Tong University publishes the most Thyroid Cancer Diagnosis and Treatment research, followed by Harvard University and Sichuan University.

Who are the leading researchers in Thyroid Cancer Diagnosis and Treatment?

The most-cited researchers publishing on Thyroid Cancer Diagnosis and Treatment include Ahmedin Jemal, Freddie Bray and Zhong Lin Wang.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Zhong Lin Wang United States 491k citations
  4. 4 George Davey Smith United Kingdom 435k citations
  5. 5 Gad A. Getz United States 364k citations
  6. 6 Hermann Brenner Germany 343k citations
  7. 7 Emelia J. Benjamin United States 341k citations
  8. 8 Jun Wang China 340k citations
  9. 9 Graeme J. Hankey Australia 316k citations
  10. 10 Gordon Henry Guyatt Canada 315k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Thyroid Cancer Diagnosis and Treatment?

The most cited paper in Thyroid Cancer Diagnosis and Treatment is "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer" (Bryan R. Haugen, Erik Karl Alexander, Keith Christopher Bible et al., 2015), with 16,719 citations. Next come "Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer" (6,774) and "Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)" (3,904).

Most cited papers
#PaperReleasedCitations
1 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Bryan R. Haugen, Erik Karl Alexander, Keith Christopher Bible et al. · Thyroid Open access 14 Oct 2015 16,719
2 Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer David S. Cooper, Gerard M. Doherty, Bryan R. Haugen et al. · Thyroid Open access 27 Oct 2009 6,774
3 Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) Joseph G. Hollowell, N Staehling, W. Dana Flanders et al. · The Journal of Clinical Endocrinology & Metabolism Feb 2002 3,904
4 Increasing Incidence of Thyroid Cancer in the United States, 1973-2002 Louise Davies, H. Gilbert Welch · JAMA 9 May 2006 3,387
5 Integrated Genomic Characterization of Papillary Thyroid Carcinoma Nishant Agrawal et al. · Cell Open access243 authors Oct 2014 3,142
All 98 most cited papers, with filters and sorting

Where is Thyroid Cancer Diagnosis and Treatment research done?

The largest centres of Thyroid Cancer Diagnosis and Treatment research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Hangzhou (China).

Largest cities, 2022-now

  1. 1 BeijingChina 299 works
  2. 2 ShanghaiChina 192 works
  3. 3 SeoulSouth Korea 189 works
  4. 4 HangzhouChina 119 works
  5. 5 GuangzhouChina 117 works
  6. 6 ChengduChina 112 works
  7. 7 New YorkUnited States 107 works
  8. 8 IstanbulTürkiye 99 works
  9. 9 RomeItaly 81 works
  10. 10 BostonUnited States 74 works
See Thyroid Cancer Diagnosis and Treatment on the map

Where is the best place to study Thyroid Cancer Diagnosis and Treatment?

Among universities, judged by research, Harvard University, China Medical University and Sun Yat-sen University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.67%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversitySun Yat-sen UniversityChina Medical Univer…Sichuan University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 73.319.8%3.2×84 -18.0%
2China Medical UniversityChina 71.417.4%16.8×58 +23.0%
3Sun Yat-sen UniversityChina 69.918.1%3.9×67 +69.7%
4Sichuan UniversityChina 66.314.6%4.0×75 +29.1%
5Seoul National UniversitySouth Korea 65.214.7%5.0×47 +9.1%
6Catholic University of KoreaSouth Korea 64.318.9%12.3×34 +7.5%
7Karolinska InstitutetSweden 64.123.0%3.5×17 +10.8%
8McGill UniversityCanada 63.025.7%2.2×18 +26.8%
9Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 60.810.2%7.6×66 +44.2%
10Fujian Medical UniversityChina 60.514.3%10.0×45 +81.3%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Thyroid Cancer Diagnosis and Treatment, country by country

Is Thyroid Cancer Diagnosis and Treatment research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Thyroid Cancer Diagnosis and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Thyroid Cancer Diagnosis and Treatment as a percentage of every work published that year, 0.038% in 2024.

still counting0.020%0.040%0.060%Thyroid Cancer Diagnosis and Treatment0.040% in 202519801990200020102020

Fractional works of Thyroid Cancer Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Thyroid Cancer Diagnosis and Treatment10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Thyroid Cancer Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.